Does DURVALUMAB Cause Rash maculo-papular? 44 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Rash maculo-papular have been filed in association with DURVALUMAB (IMFINZI). This represents 0.3% of all adverse event reports for DURVALUMAB.
44
Reports of Rash maculo-papular with DURVALUMAB
0.3%
of all DURVALUMAB reports
5
Deaths
17
Hospitalizations
How Dangerous Is Rash maculo-papular From DURVALUMAB?
Of the 44 reports, 5 (11.4%) resulted in death, 17 (38.6%) required hospitalization, and 2 (4.5%) were considered life-threatening.
Is Rash maculo-papular Listed in the Official Label?
Yes, Rash maculo-papular is listed as a known adverse reaction in the official FDA drug label for DURVALUMAB.
What Other Side Effects Does DURVALUMAB Cause?
Death (2,817)
Malignant neoplasm progression (1,330)
Pneumonitis (827)
Radiation pneumonitis (786)
Pyrexia (573)
Diarrhoea (530)
Pneumonia (453)
Dyspnoea (444)
Interstitial lung disease (430)
Off label use (395)
What Other Drugs Cause Rash maculo-papular?
SULFAMETHOXAZOLE\TRIMETHOPRIM (935)
AMOXICILLIN (871)
VANCOMYCIN (642)
PIPERACILLIN\TAZOBACTAM (629)
PANTOPRAZOLE (589)
LAMOTRIGINE (568)
ALLOPURINOL (550)
CARBOPLATIN (529)
ACETAMINOPHEN (499)
CLINDAMYCIN (484)
Which DURVALUMAB Alternatives Have Lower Rash maculo-papular Risk?
DURVALUMAB vs DUTASTERIDE
DURVALUMAB vs DUTASTERIDE\TAMSULOSIN
DURVALUMAB vs DUVELISIB
DURVALUMAB vs DYDROGESTERONE
DURVALUMAB vs EBASTINE